Retina omplant has announced the opening of a new manufacturing plant to meet the anticipated demand for its subretinal implant technology. The implant technology will be undergoing second human clinical trials throughout Europe, including the UK and Italy, with discussionss currently underway for theres trials to also move to the US and Asia.
"Pending positive results of the second human clinical trial currently underway, our new manufacturing facility will position us to make our implants available quickly to patients in need" affirmed Walter G. Wrobel, CEO of Retina Implant-
In addition meeting demand, the new facility adheres to manufacturing requirements for CE mark approval.
No comments:
Post a Comment